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Abstract
Objective: Metabolic Syndrome (MetS) is a cluster of Cardio-Vascular Disease (CDV) risk factors including
visceral obesity, hyperglycemia, hypertension, low HDL cholesterol, hypertriglyceridemia and increased oxidative
stress. Pyrene-lipid derivatives selectively incorporated into the hydrophobic core and surrounding amphipathic
envelope of LDLs and HDLs are useful markers of the oxidizability of these lipoprotein regions. We performed an
observational study aimed at investigating the effect of lipid composition, in particular triacylglycerol (TAG) levels, on
the oxidizability of the core and the envelope of LDLs and HDLs in MetS.
Methods: We induced changes in the chemical composition of lipoprotein in vivo by placing on a hypocaloric
balanced diet fifteen overweight and moderately obese men (BMI: 25-35 kg/mq) with MetS until they lost at least 5%
of their initial weight. The core and the surface of LDLs and HDLs were labeled with selective pyrenic probes.
Susceptibility to 2,2'-azobis-2-methyl-propanimidamide-dihydrochloride-induced peroxidation was measured
following kinetically the decrease of fluorescence of these probes. The length of the lag phase (lag-time) of
peroxidation kinetic were calculated and used as indices of lipoprotein oxidizability. In addition, we measured
paraoxonase activity and plasma oxidative status.
Results: After weight loss, together with a reduction of triglyceridemia and the improvement of the other CDV risk
factors associated with MetS, we observed a massive transfer of TAG from HDLs toward LDLs. In the LDLs core,
the increased TAG concentration halved the resistance to peroxidation, while in the HDLs core the reduction of this
parameter doubled the value of lag-time. In the lipoprotein hydrophobic cores, the duration of lag-time correlated
directly with ratio between cholesteryl esters and TAG. No significant changes were found in paraoxonase activity
and plasma oxidative status.
Conclusions: Less oxidizable HDLs, but also more oxidizable LDLs seem to accompany the improvement of
different metabolic factors induced by weight loss in obese men with MetS.
Keywords: Triacylglycerol; Metabolic syndrome; LDL; HDL;
Lipoprotein oxidation; Caloric restriction; Weight loss
Abbreviations AAPH: 2,2′-azobis (2-methylpropionamidine)
dihydrochloride; BMI: Body Mass Index; CE: Cholesteryl Esters;
CETP: Cholesterol Ester Transfer Protein; CRP: C-reactive Protein,
DCF-DA: Dichlorofluorescin-diacetate; DTPA: Diethylene Triamine
Pentaacetic Acid; HOMA-IR: Homeostatic Model of Assessment for
Insulin Resistance; LCAT: Lecithin-Cholesterol Acyltransferase;
LOOH: Lipid Peroxides; MDA: Malondialdehyde; MetS: Metabolic
Syndrome; PyrPC: β-(pyren-1-yl) Decanoyl γ-palmitoyl L-α
Phosphatidylcholine; PyrCE: Cholesteryl (pyren-1-yl) Hexanoate;
PON-1: Paraoxonase; PUFA: Polyunsaturated Fatty Acids; PL:
Phospholipids; ROS: Reactive Oxygen Species; TAG: Triacylglycerols;
TRAP: Total Peroxyl Radical-trapping Potential
Introduction
The oxidation of Low-Density Lipoproteins (LDLs) is recognized as
one of the major trigger elements of atherosclerosis progression. This
process is regulated by several factors, such as the concentration of
Reactive Oxygen Species (ROS) released by the stressed tissues, in
particular vascular endothelium, the oxidizability of LDLs, and the
protective effect of High-Density Lipoproteins (HDLs). Reverse
cholesterol transport from the peripheral tissues is the best-known and
salient activity of HDLs; however, they have other potential cardio-
protective actions. In fact, mainly because of their antioxidant and
anti-inflammatory properties, HDLs prevent the formation of oxidized
LDLs and contribute to the neutralization of their effects [1,2], remove
lipid hydroperoxides from tissues [3,4], and inhibit both platelet
aggregation [5] and endothelial cell adhesion molecule expression [6].
Moreover, paraoxonase-1 (PON-1), an aryldialkylphosphatase capable
of hydrolyzing a wide variety of substrates including toxic oxidized
lipids, circulate associated to HDLs. PON-1 activity can vary by over
40 fold between individuals, mainly because of genetic polymorphisms
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[7]; however, its enzymatic activity is modulated also by dietary
factors, in particular lipids, and is inhibited by oxidized lipids [8].
Oxidative modification and changes in the chemical composition can
reduce the functionality of HDLs and their associated enzymes [9-11].
Lipoproteins are formed by a core of hydrophobic lipids surrounded
by an envelope of amphipathic lipids and proteins, and each of these
components contributes to determine lipoprotein susceptibility to
oxidation. The relationships between the lipid components of LDLs
(especially fatty acids and cholesterol) and their susceptibility to
oxidation has been widely investigated [12-14], while such information
on HDLs is scarce. However, even if TAG are considered an important
biomarker of cardiovascular disease risk because of their association
with atherogenic remnant particles and apo C-III (a pro-inflammatory
and pro-atherogenic apolipoprotein) [15], a direct role of these
compounds in the atherogenic process has not yet been established. In
addition, lipoprotein oxidizability has been principally investigated
considering the entire lipoprotein particle. Nevertheless, we have
previously shown that pyrene-lipid derivatives selectively incorporated
into the hydrophobic core and surrounding amphipathic envelope of
LDLs and HDLs are useful markers of the oxidizability of the region in
which they are localized [16]. In addition, using pyrene labelled HDLs,
we have also demonstrated that a higher ratio between the TAG and
Cholesteryl Esters (CE) dramatically increased the fluidity and the
oxidizability of hydrophobic core of HDLs in mixed dyslipidemic men
[17].
Metabolic Syndrome (MetS) is a condition associated with obesity,
especially abdominal obesity, characterized by increased oxidative
stress, hypertriglyceridemia and low levels of HDL-cholesterol together
with abnormal glucose tolerance and hypertension. MetS dyslipidemia
is promoted by an impaired cellular response to insulin stimulation
(insulin resistance) of target tissues, primarily liver, muscle, and
adipose tissue. All the conditions that characterize MetS are among the
leading causes of deaths worldwide, in addition MetS increases the risk
of type 2 diabetes mellitus fivefold and cardiovascular disease threefold
[18]. MetS hypertriglyceridemia is characterized by an increase of TAG
in all lipoprotein classes [19]. An augmented ratio between TAG and
CE in HDLs hydrophobic core contributes to a great clearance of this
class of lipoproteins by the kidney [19], and, as mentioned above,
increases the susceptibility to oxidation and changes the fluidity status
of the hydrophobic core of these particles [17]. However, to the best of
our knowledge, the role of TAG in the oxidizability of LDLs and HDLs
hydrophobic cores in MetS has not yet been thoroughly investigated.
Lipid composition of lipoproteins is influenced by genetic factors,
disease conditions and lifestyle. It can be modified ex-in vivo by
incubating plasma with different lipids or in vivo by changes in life
style and/or weight loss. Moreover, intentional weight loss can improve
dyslipidemia and oxidative stress and these metabolic benefits are
often found after modest weight loss (5% of initial weight) [20].
We performed a pilot study with the aim to investigate the effect of
lipid composition, in particular of TAG levels, on the oxidizability of
LDLs and HDLs in MetS. To this purpose, we induced changes in the
chemical composition of lipoprotein in vivo by placing on a
hypocaloric balanced diet obese men with MetS until they had lost at
least 5% of their initial weight, and we studied the effects of these
changes on the oxidizability of the hydrophobic core and the
surrounding amphipathic surface of LDLs and HDLs. In addition, we
investigated also the effects of diet-induced weight loss on PON-1
activity and plasma oxidative status.
Materials and Methods
Materials
Organic solvent (analytical grade) and the other chemicals were
purchased from Sigma-Aldrich (Milan, Italy) with the exception of the
d-ROMs kit that was purchased from Diacron International (Grosseto,
Italy).
Subjects
The subjects included in the present study were originally part of the
“Oxidative Stress, Inflammation, and Lipoprotein in Metabolic
Syndrome” study (ClinicalTrials.gov Identifier: NCT03553381). From
this cohort we defined and selected 15 overweight and moderately
obese Caucasian men (25 kg/m2<BMI<35 kg/m2) who on enrollment
had metabolic syndrome defined according to International Diabetes
Federation (i.e., waist circumference>94 cm plus any two of the
following four components: 1) triglyceride level ≥ 150 mg/dL2); 2)
HDL cholesterol<40 mg/dL; 3) raised Blood Pressure (BP): systolic BP
≥ 130 or diastolic BP ≥ 85 mmHg or antihypertensive medication; 4)
fasting plasma glucose ≥ 100 mg/dL) [21] and who after following a
Mediterranean-style balanced hypo-caloric diet had lost at least 5% of
their initial weight. The study was approved by the ethics committees
of the Istituti Clinici di Perfezionamento of Milan and of L. Sacco
Hospital of Milan and was carried out in accordance with the
principles of the Declaration of Helsinki as revised in 2000. Subjects
gave their written consent to the study.
Blood collection and analyses
Overnight fast blood was drawn from the men (12 hrs without
food) in the morning at study entry and at the end of treatment.
Moreover, men refrained from participating in any form of physical
activity for 48 hrs before the study. Blood collection and handling were
carried out under strictly standardized conditions and in line with
manufacturer recommendations. Blood for clinical chemistry
parameters and d-ROMs measurement was collected into evacuated
tubes without anticoagulant, and then centrifuged for 15 mins at 1500x
g. EDTA-plasma was used for lipoprotein isolation and paraoxonase
activity determination.
Lipoprotein isolation, characterization and peroxidation
Lipoproteins were isolated from plasma as previously described
[17]. After separation, lipoprotein were dialyzed and their levels of
proteins, cholesterol (total and free), phospholipid and triacylglycerols,
α-tocopherol and β-carotene were determined as previously described
[16,22].
We incorporated cholesteryl (pyren-1-yl) hexanoate (PyrCE) or β-
(pyren-1-yl) decanoyl γ-palmitoyl L-α phosphatidylcholine (PyrPC) in
their monomeric forms into lipoprotein to measure the oxidizability of
the hydrophobic core and surrounding amphipathic envelope, as
previously described [16]. Labelled lipoproteins were resuspended (100
µg protein/mL) in phosphate-buffered saline pH 7.4, supplemented
with 50 mM DTPA to chelate redox-active metal ions, and peroxidized
at 37°C by incubation with AAPH 1 mM at 37°C [17]. The length of
the lag phase (lag-time) and the velocity of the reaction in the
propagation phase (slope) of peroxidation kinetic were calculated and
used as indices of lipoprotein oxidizability [17].
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Paraoxonase activities, total peroxyl radical-trapping
antioxidant potential (TRAP) and reactive oxygen
metabolites (d-ROMs)
Plasma PON-1 activities was assayed in plasma using two synthetic
substrates: paraoxon (diethyl-p-nitrophenyl phosphate) and phenyl
acetate. The activity toward paraoxon (paraoxonase activity) was
calculated using a molar extinction coefficient of 18,290 M-1 cm-1,
whereas that toward phenyl acetate (arylesterase activity) was
calculated using a molar extinction coefficient of 1310 M-1 cm-1. The
results are expressed in UmL-1.
Plasma diluted to 5% in phosphate-buffered saline solution pH 7.4
(PBS) was used for the determination of total peroxyl radical–trapping
potential (TRAP) as previously described using Trolox as reference
standard [23].
The reactive oxygen metabolites (d-ROMs) assay was carried out by
adapting the manufacturer's protocol to a 96-well-plate format. d-
ROMs concentration of the samples was calculated using a serum
standard and expressed as equivalent of H2O2 according to
manufacturer’s instruction.
Statistics
Since the Kolmogorov–Smirnov normality test revealed non-normal
distribution of the parameters, results were presented as median SEM.
The effects of hypo-caloric diet were analyzed by paired comparison
(values before vs. after the intervention) using Wilcoxon tests. Two-
tailed p-values ≤ 0.05 were considered significant. The linear
relationships between the covariates were assessed using non-
parametric Spearman Rank Correlation. A p-value ≤ 0.05 was
considered statistically significant. All statistical analyses were
performed by using StatistiXL software (version 1.5; StatistiXL,
Western Australia).
Results
The hypocaloric diet determined a weight reduction of 7.4 0.6% in
initial weight and significantly decreased BMI by 2.6 0.2 Kg/m2. In
Table 1 are summarized the anthropometric, blood pressure and blood
parameter values before and after weight loss. All the risk factors
associated to MetS improved significantly, with the exception of HDLs
cholesterol, which was unchanged. In addition, the diet treatment
improved total cholesterol, insulin, HOMA-IR, and CPR.
 T0 T1
BMI (kg/m2) 33.7 ± 0.8 30.6 ± 0.7**
Waist circumference (cm) 110 ± 2.5 104 ± 1.8**
Systolic blood pressure (mmHg) 140 ± 3.9 126 ± 3.5*
Diastolic blood pressure (mmHg) 90 ± 2.4 80 ± 2.4**
Glycaemia (mg/dL) 101 ± 5.2 93 ± 4.3*
Insulin (µU/L) 11.4 ± 1.5 6.8 ± 1.0*
HOMA-IR 2.6 ± 0.4 1.7 ± 0.3**
Triacylglycerols (mg/dL) 122 ± 18 104 ± 10.0*
HDL cholesterol (mg/dL) 44 ± 2.8 47 ± 2.6
Cholesterol (mg/dL) 196 ± 6.8 170 ± 7.5*
Uric acid (mg/dL) 6.7 ± 0.4 6.4 ± 0.4
CRP (mg/L) 0.4 ± 0.1 0.1 ± 0.1*
Note: Data are expressed as median ± SEM; *p ≤ 0.05; **p ≤ 0.01.
Table 1: Anthropometric characteristics, blood pressure and blood parameters of subjects before (T0) and after (T1) weight loss.
As expected, a hypocaloric diet changed dramatically also
lipoprotein chemical composition (Table 2). Weight loss significantly
decreased the protein concentration of LDLs, while it increased that of
HDLs. As regards LDLs, because almost all of its protein content
consists of one molecule of apo B-100, the decrease in protein levels is
indicative of a reduction in the concentration of these lipoproteins. On
the other hand, the changes of protein concentrations in HDLs can be
ascribed to both variations of lipoprotein levels and modifications of
Apo contents. Weight loss changed also the lipid composition, in
particular the concentration of TAG, which significantly increased in
LDLs while decreasing in HDLs. To understand better the variation in
the composition of lipoproteins, we calculated the relative percentage
of lipid weight distribution to total lipid mass. The changes of TAG
levels significantly influenced the relative distribution of the other
lipids. In particular, we observed a significant decrease in the
percentage of phospholipids and both free and esterified cholesterol in
LDLs, and a significant increase in the percentage of phospholipids and
cholesteryl esters in the in HDLs. The proportions between total
neutral lipids and beta-carotene as well as the ratio between alpha-
tocopherol and phospholipids were not significantly influenced by
weight loss (data not shown).
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 LDL HDL
T0 T1 T0 T1
Protein (mg/dL) 123 ± 10 105 ± 8* 82 ± 20 100 ± 29*
FC (mg/dL) 19.4 ± 1.4 18.8 ± 1.4 5.1 ± 0.4 5.0 ± 0.4
CE (mg/dL) 83.4 ± 6.1 81.0 ± 5.9 39.3 ± 2.9 39.8 ± 2.9
TAG (mg/dL) 44.6 ± 3.1 57.0 ± 4.6** 31.1 ± 2.3 25.3 ± 1.8**
PL (mg/dL) 77.2 ± 4.6 68.2 ± 4.9 49.7 ± 3.7 47.4 ± 3.3
CE/TAG 1.79 ± 0.1 1.43 ± 0.1** 1.36 ± 0.1 1.75 ± 0.1**
PL/FC 3.83 ± 0.1 3.69 ± 0.1 9.68 ± 0.1 9.20 ± 0.1*
FC (%w/w) 8.7 ± 0.1 8.3 ± 0.1** 4.2 ± 0.1 4.5 ± 0.1**
CE (%w/w) 37.3 ± 0.5 35.7 ± 0.6** 31.8 ± 0.5 34.4 ± 0.4**
TAG (%w/w) 20.9 ± 0.5 25.5 ± 0.6** 23.8 ± 0.4 19.6 ± 0.4**
PL (%w/w) 33.3 ± 0.3 31.6 ± 0.4** 40.0 ± 0.4 41.5 ± 0.4*
Note: Data are expressed as median ± SEM; * p ≤ 0.05; **; p ≤ 0.01; TAG: Triacylglycerols; PL: Phospholipids; FC: Free Cholesterol; CE Cholesteryl Esters. 
Table 2: Protein (Apo) and lipid concentrations of lipoproteins before (T0) and after (T1) weight loss.
The values of parameters indicative of the oxidative status of LDLs
and HDLs are reported in Figure 1. Panel A of Figure 1 depicts the
resistance to oxidation (lag-time of the curves of peroxidation kinetic)
of hydrophobic core and amphiphilic surface of both LDLs and HDLs
before and after diet-induced weight loss. At baseline, the values of lag-
time were similar in the core and surface of LDLs as well as in the core
and surface of HDLs; however, the resistance to oxidation of LDLs is
significantly higher than that of HDLs. After weight loss, resistance to
oxidation of the core changed significantly and in the opposite
direction: the value of lag-time of core increased in LDLs while it
decreased in HDLs. However, in the surface there was only a
significant reduction of lag-time of LDLs, while that of HDLs remained
almost unchanged. Panel B reports the peroxidation rate (slope of the
curve of peroxidation kinetic) of hydrophobic core and amphiphilic
surface of both LDLs and HDLs before and after diet-induced weight
loss. Weight loss influenced only the peroxidation rate of HDLs core by
significantly decreasing and thus improving the slope of the
peroxidation curve.
The susceptibility to oxidation of lipoproteins significantly
correlated with the chemical compositions of LDLs and HDLs. In the
hydrophobic cores, the duration of lag-time correlated directly with
CE/TAG ratio (R=0.68, p=0.0006 and R=0.51, p=0.0174; respectively)
and indirectly with the percentage of TAG (R=-0.66, p=0.0011 and
R=-0.53, p=0.0125 respectively) and the TAG/PL ratio (R=-0.45,
p=0.0411 and R=-0.44, p=0.0446; respectively). Moreover, the slope of
LDLs correlated negatively with the protein levels (R=-0.46, p=0.0342),
as well as the lag-time of HDLs with the concentration of PL (R=-0.48,
p=0.0293). In the surface, the lag-time of HDLs correlated negatively
with the concentration of protein and PL (R=-0.48, p=0.0289 and
R=-0.49, p=0.0250 respectively).
Figure 1: Values of lag-time (panel A) and slope (panel B) of the
peroxidation kinetic curves in the hydrophobic core and
amphiphilic surface of LDLs and HDLs before (blank bars) and
after (grey bars) diet-induced weight loss.
Citation: Cazzola R, Piuri G, Garziano M, Cassani E, Boggio A, et al. (2018) The Role of Triacylglycerol in the Oxidizability of Low Density
Lipoproteins and High Density Lipoproteins: Possible Contributions to Atherosclerosis in Metabolic Syndrome. J Obes Weight Loss
Ther 8: 378. doi:10.4172/2165-7904.1000378
Page 4 of 7
J Obes Weight Loss Ther, an open access journal
ISSN:2165-7904
Volume 8 • Issue 6 • 1000378
Paraoxonase activities, reactive oxygen metabolites (d-ROMs) levels
and peroxyl radical–trapping potential (TRAP) of plasma are reported
in Table 3. Weight loss has led to a slight, but not significant, increase
in both PON-1 activities (paraoxonase and arylesterase). d-ROMs and
TRAP seem not to have been affected by weight loss. However, because
uric acid is one of the major contributors to TRAP and weight loss
determined a slight, though not significant, decrease in its
concentration (Table 1), we calculated the impact of uric acid on
TRAP, assuming that 1 mole of uric acid traps 1.34 moles of AAPH
radicals [24]. The TRAP values without uric acid contribution (TRAP-
U) were increased after weight loss but they did not reach statistical
significance.
 T0 T1
Paraoxonase (U/mL) 117 ± 23.9 108 ± 19.5
Arylesterase (U/mL) 69.7 ± 4.6 69.6 ± 3.3
ROS (mg/dL H2O2) 27.6 ± 0.8 28.1 ± 0.5
TRAP (TE) 2222 ± 224.6 2033 ± 119.9
TRAP- U (TE)* 1674.9 ± 224.3 1745.8 ± 102.8
Note: Data are expressed as median ± SEM; * TRAP values without uric acid contribution, calculated by subtracting the radical trapped by uric acid assuming that 1
mole of uric acid trap 1.34 moles of AAPH radicals.
Table 3: PON-1 activities, reactive oxygen species (ROS) and total peroxyl radical–trapping potential (TRAP) of plasma before (T0) and after (T1)
weight loss.
Discussion
In the present study, we found that changes in lipoprotein chemical
composition obtained through diet-induced weight loss had opposite
effects on the oxidizability of LDLs and HDLs in overweight and I
grade obese men with MetS, in particular at the level of their
hydrophobic cores.
Weight loss significantly changed the concentrations of proteins and
lipids in lipoproteins. In particular, we have observed that the protein
concentration decreased in LDLs, while increased in HDLs. These
changes are in alignment with previous studies showing that weight
reduction decreases the concentrations of Apo B-100 [25] and
increases the levels of Apo A-I [26] in subjects with MetS. As regards
lipids, apart from a decrease in the levels of total TAG in plasma, we
also observed a massive transfer of TAG from HDLs toward LDLs and,
consequently, changes in the relative distribution of the other lipids. In
HDLs, the decrease of TAG percentage was accompanied by a
significant increase of percentage of both CE in the hydrophobic core
and surface lipids. On the other hand, in LDLs the increase of TAG
percentage was associated with a significant decrease of percentage of
both CE and surface lipids. As suggested by previous studies showing
that lipoprotein dimensions are inversely related to their TAG content
[11,27], these changes are compatible with an increase of HDL
dimensions and a reduction of LDL size. All these variations are the
result of changes in the activity and/or concentration of proteins and
enzymes involved in lipoprotein metabolism. Previous studies have
demonstrated that weight loss induces in subjects with MetS: a) a
decrease in concentration of apo C-III promoting the action of
lipoprotein lipase and the consequent decrease of triglyceridemia [25];
b) a reduction of catabolism of apo A-I, an activator of lecithin
cholesterol acyl transferase (LCAT, an enzyme that enrich the HDL
core of cholesteryl ester) [26]; and c) a decrease in the mass of both
cholesteryl ester transfer protein (the major lipid transfer protein in
serum that collects triglycerides from VLDLs or LDLs and exchanges
them for CE from HDLs, and vice versa) and phospholipid transfer
protein [28,29].
As regards lipoprotein oxidizability, at baseline, the duration of lag-
time (indicative of the resistance to peroxidation) of the surface was
similar to this of the core in LDLs as well as in HDLs, but LDLs had a
higher resistance to peroxidation than HDLs. Similarly, the slopes
(indicative of the propagation rate of the peroxidation processes) of the
surface was similar to that of the core in LDLs as well as in HDLs, but
the propagation rates of peroxidation in LDLs were lower than in
HDLs. Collectively, these results indicate that the lipid radicals derived
from AAPH-induced reactions had the same chance of propagating
peroxidation towards the adjacent lipids of both the cores and the
surfaces and, moreover, that HDLs were more susceptible to oxidation
than LDLs in our cohort study.
The changes of lipid composition influenced significantly the
oxidizability of LDLs and HDLs but in opposite ways: the first got
worse, while the latter were improved. In fact, in the LDL core, the
increased ratio between TAG and CE approximately halved the
resistance to peroxidation, while in the HDL core the reduction of this
ratio doubled the value of lag-time. The direct correlation that we
found between CE to TAG ratio and the duration of lag-time in the
hydrophobic cores of LDLs and HDLs is further confirmation of the
key role played by TAG in the processes of peroxidation of
lipoproteins. In addition, hypocaloric diet did not influence
proportions between total neutral lipids and beta-carotene and
between alpha-tocopherol and phospholipids. It is well known that the
peroxidation kinetic of lipoproteins is not only influenced by the
concentration of pro-oxidants, oxidizable lipids and antioxidants, but
also by the complex interactions that are established between these
factors. At lipid level, the fluidity of the microenvironment in which a
chemical reaction occurs strongly influences the interactions between
the molecules involved in the process: the greater the degree of fluidity,
the greater the likelihood of interaction between molecules. TAG are
more oxidizable than CE [30] and has been shown to be directly
correlated to the degree of fluidity of lipoprotein hydrophobic cores
[17] because of their conformation and a higher content in unsaturated
fatty acids. The fluidizing and oxidizing actions of TAG in LDL core
could be responsible also for the reduction of lag-time in LDL envelope
after weight loss. Moreover, as mentioned above, lipoprotein
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dimensions are inversely related to their TAG content and the size of
LDLs and HDLs seems to be related to their oxidizability: the higher
the dimension, the lower the oxidizability [11,27].
Differently than in LDLs and HDLs, the plasma oxidative stress
status - assessed by measuring TRAP (an index of the cooperative
activity of different plasma antioxidant) and d-ROMS (indicative of
oxidative damage to serum lipid) has not been significantly influenced
by weight loss. Moreover, these results seem to indicate that the
reduced oxidizability of HDLs is counterbalanced by the increased
oxidizability of LDLs at plasma level. Our findings agree with Crujeiras
et al who have not found significant variations of plasma total
antioxidant capacity and concentration of malondialdehyde (a marker
of lipid peroxidation) in obese women (BMI: 34.9 2.9 kg/m2) treated
with a hypocaloric diet that lead to a weight loss similar to that
obtained by our subjects [31]. Nevertheless, several other studies in
which different therapeutic approaches were used and diverse
oxidative stress markers were measured have shown a positive effect of
weight loss on oxidative stress status in subjects with different grade of
obesity [31-33]. However, different modes of therapeutic intervention
to achieve weight loss may lead to differing effects on oxidative stress
status. In addition, the arylesterase and paraoxonase activities of
PON-1 did not change after weight loss. However, the activity of this
HDL-associated enzyme has been shown to be mainly influenced by
genetic polymorphisms [7].
Conclusion
Although this study provides useful new information on the
oxidizability of the hydrophobic core and amphipathic surface of
lipoproteins after weight loss and highlights the important, and often
underestimated, role of TAG in lipoprotein oxidizability, some
limitations may also be discussed. First, the study population was
relatively small and it was limited to male subjects. Therefore, the
conclusions should not be generalized to all patients with MetS. Lastly,
although it is recognized that the oxidizability of lipoproteins may play
a role in the development of atherosclerosis, the validity of assay
performed in vitro to predict the in vivo progression of atherosclerosis
has yet to be proven.
In conclusion, more anti-atherogenic HDLs, but also more
oxidizable LDLs seem to accompany the improvement of different
metabolic factors induced by weight loss in obese men with MetS. This
different response to weight loss is mainly related to the content of
TAG in lipoprotein hydrophobic core. Thus, besides the well-
established role of hypertriglyceridemia and its associated condition as
risk factor for CVD, our results seem to indicate a potential direct
involvement of lipoprotein TAG in the development of atherosclerosis.
In addition, collectively our findings suggest that detailed knowledge
of the oxidizability of both the surface and core of lipoproteins could
be an additional means to clarify the mechanisms that links the
changes of lipoprotein metabolism at risk of CVD in patients with
MetS. Moreover, these parameters could be useful biomarkers in future
studies on new dietary and therapeutic approaches for the treatment of
obese subjects with MetS.
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